Cochrane Review Group
Common Mental Disorders
117 systematic reviews in Common Mental Disorders ask 2,206 questions. 17.5% have no studies to answer them, 28.8% rest on very low certainty evidence and 22.9% reach moderate or high certainty.
Reviews
117
Questions
2,206
current versions
No studies
17.5%
Moderate or high
22.9%
No studies 387 · 17.5%Ungraded 111 · 5%Very low 635 · 28.8%Low 568 · 25.7%Moderate 449 · 20.4%High 56 · 2.5%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Thinnest evidence
All no studies and very low questions| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Any psychological therapy vs any non‐therapy comparator: end‐of‐intervention and short‐term follow‐up Depressive symptomatology (lower = less depressive symptomatology): end‐of‐intervention · older people with depression Psychological therapies for depression in older adults residing in long‐term care settings (2024) · Cochrane | no estimate extracted | 18 studies · 644 participants | Very low |
Any psychological therapy vs any non‐therapy comparator: end‐of‐intervention and short‐term follow‐up Treatment non‐acceptability (higher = greater non‐acceptability): end‐of‐intervention · older people with depression Psychological therapies for depression in older adults residing in long‐term care settings (2024) · Cochrane | no estimate extracted | 5 studies · 313 participants | Very low |
Any psychological therapy vs any non‐therapy comparator: end‐of‐intervention and short‐term follow‐up Depression remission (presence or absence of MDD):end‐of‐intervention · older people with depression Psychological therapies for depression in older adults residing in long‐term care settings (2024) · Cochrane | no estimate extracted | 1 study · 82 participants | Very low |
Any psychological therapy vs any non‐therapy comparator: end‐of‐intervention and short‐term follow‐up Quality of life or psychological well‐being (higher = higher quality of life or psychological well‐being): end‐of‐intervention · older people with depression Psychological therapies for depression in older adults residing in long‐term care settings (2024) · Cochrane | no estimate extracted | 6 studies · 195 participants | Very low |
Any psychological therapy vs any non‐therapy comparator: end‐of‐intervention and short‐term follow‐up Anxious symptomatology (lower = less anxious symptomatology): end‐of‐intervention · older people with depression Psychological therapies for depression in older adults residing in long‐term care settings (2024) · Cochrane | no estimate extracted | 2 studies · 115 participants | Very low |
Escitalopram vs placebo PTSD severity at 3 months · adults experiencing acute traumatic stress symptoms Early pharmacological interventions for prevention of post‐traumatic stress disorder (PTSD) in individuals… (2024) · Cochrane | no estimate extracted | 1 study · 23 participants | Very low |
Hydrocortisone vs placebo Quality of life at 3 months · adults experiencing acute traumatic stress symptoms Early pharmacological interventions for prevention of post‐traumatic stress disorder (PTSD) in individuals… (2024) · Cochrane | no estimate extracted | 1 study · 43 participants | Very low |
Escitalopram vs placebo Dropouts due to adverse events at 3 months · adults experiencing acute traumatic stress symptoms Early pharmacological interventions for prevention of post‐traumatic stress disorder (PTSD) in individuals… (2024) · Cochrane | no estimate extracted | 1 study · 31 participants | Very low |
Escitalopram vs placebo PTSD rate at 3 months · adults experiencing acute traumatic stress symptoms Early pharmacological interventions for prevention of post‐traumatic stress disorder (PTSD) in individuals… (2024) · Cochrane | RR 0.59 [0.03, 13.08] | 1 study · 23 participants | Very low |
Escitalopram vs placebo Functional disability at 3 months ‐ not measured · adults experiencing acute traumatic stress symptoms Early pharmacological interventions for prevention of post‐traumatic stress disorder (PTSD) in individuals… (2024) · Cochrane | no estimate extracted | NR | No studies |
Escitalopram vs placebo Quality of life at 3 months ‐ not measured · adults experiencing acute traumatic stress symptoms Early pharmacological interventions for prevention of post‐traumatic stress disorder (PTSD) in individuals… (2024) · Cochrane | no estimate extracted | NR | No studies |
Hydrocortisone vs placebo PTSD severity at 3 months · adults experiencing acute traumatic stress symptoms Early pharmacological interventions for prevention of post‐traumatic stress disorder (PTSD) in individuals… (2024) · Cochrane | no estimate extracted | 3 studies · 136 participants | Very low |
Reviews 117
Melatonin and agomelatine for preventing seasonal affective disorder
CochraneSoF table
6 questions
Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease
CochraneSoF table
15 questions
Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults
CochraneSoF table
2 questions
Present‐centered therapy (PCT) for post‐traumatic stress disorder (PTSD) in adults
CochraneSoF table
5 questions
Pharmacy‐based management for depression in adults
CochraneSoF table
8 questions
Acupuncture for depression
CochraneSoF table
20 questions
Couple therapy for depression
CochraneSoF table
16 questions
Antidepressants for preventing postnatal depression
CochraneSoF table
12 questions
Antidepressants for depression in adults with HIV infection
CochraneSoF table
15 questions
Psychological therapies for treatment‐resistant depression in adults
CochraneSoF table
17 questions
Antidepressants versus placebo for panic disorder in adults
CochraneSoF table
28 questions
Eszopiclone for insomnia
CochraneSoF table
7 questions
Antidepressants for insomnia in adults
CochraneSoF table
12 questions
Client feedback in psychological therapy for children and adolescents with mental health problems
CochraneSoF table
5 questions
Psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises
CochraneSoF table
10 questions
Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease
CochraneSoF table
14 questions
Psychological therapies for anxiety and depression in children and adolescents with long‐term physical conditions
CochraneSoF table
7 questions
E‐Health interventions for anxiety and depression in children and adolescents with long‐term physical conditions
CochraneSoF table
6 questions
Pharmacotherapy for social anxiety disorder (SAnD)
CochraneSoF table
62 questions
Music therapy for depression
CochraneSoF table
21 questions
Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease
CochraneSoF table
5 questions
Vortioxetine for depression in adults
CochraneSoF table
14 questions
Cognitive behavioural therapy (CBT), third‐wave CBT and interpersonal therapy (IPT) based interventions for preventing depression in children and adolescents
CochraneSoF table
6 questions
Topiramate for acute affective episodes in bipolar disorder in adults
CochraneSoF table
29 questions
Continuation and maintenance treatments for depression in older people
CochraneSoF table
2 questions